Sentry LLC’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
VCM
VPM
Sentry LLC's AMGN Position: Q1 2026 in Review
Sentry LLC reduced its Amgen (AMGN) stake by 3.4% in Q1 2026, selling an estimated $177K and leaving 13,941 shares worth $4.91M. The position accounts for 1.56% of the portfolio, ranked #12.
Sentry LLC first reported a position in AMGN in Q1 2023 and has held it in 13 quarters since. 3,126 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.
- Sentry LLC held 13,941 shares of Amgen worth $4.91M as of Q1 2026.
- Sentry LLC sold 496 Amgen shares in Q1 2026, an estimated $177K.
- Amgen made up 1.56% of Sentry LLC's portfolio in Q1 2026, its #12 holding.
- Sentry LLC first reported a position in Amgen in Q1 2023 and has held it in 13 quarters since.
- 3,126 funds tracked by Wall St. Rank held Amgen as of Q1 2026.
Based on Sentry LLC's 13F filing for Q1 2026, filed 23 Apr 2026.